Introduction Case study: introduction SMAA(-2)

First Page		Document Content
Date: 2013-12-04 08:49:49 Drug safety Pharmaceuticals policy Pharmacy Cough medicine Merck Evidence-based medicine Randomized controlled trial Schering-Plough Meta-analysis Medicine Science Health		Introduction Case study: introduction SMAA(-2) Add to Reading List Source URL: drugis.org Download Document from Source Website File Size: 2,41 MB Share Document on Facebook

	Practice Based Evidence for Treatment of Pregnancy and Anthracycline Cardiomyopathy JEAN-BERNARD DURAND, M.D., FCCP, FACC,FACP,FHFSA,FAHA PROFESSOR OF MEDICINE DocID: 1vjaw - View Document
	UNIVERSITY OF SPLIT SCHOOL OF MEDICINE announces APPLICATIONS OPEN FOR UNIVERSITY POSTGRADUATE DOCTORAL STUDY PROGRAM «EVIDENCE-BASED MEDICINE» DocID: 1vaic - View Document
	Who decides when to apply Evidence-Based Medicine? Felipe Rocha L. Santos Evidence Based Medicine (EBM) is supposed to be one of the most important tools for medical practice related to decision-making. If we have good e DocID: 1v3FV - View Document
	The evidence that evidence-based medicine omits Brendan Clarke, Donald Gillies, Phyllis Illari, Federica Russo, Jon Williamson** Department of Science and Technology Studies, University College London *Center Le DocID: 1ujM1 - View Document
	THE SECTION ON EVIDENCE BASED HEALTH CARE of The New York Academy of Medicine DATE & TIME March 20-21, 2017 REGISTRATION DocID: 1tqRa - View Document